Published in Mol Biochem Parasitol on October 30, 1998
Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int (2011) 1.71
Substrate specificity and redox potential of AhpC, a bacterial peroxiredoxin. Proc Natl Acad Sci U S A (2007) 1.62
Role of superoxide dismutase in survival of Leishmania within the macrophage. Biochem J (2003) 1.12
Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis. BMC Infect Dis (2007) 1.11
Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates. Mol Biochem Parasitol (2010) 1.05
Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials. Antimicrob Agents Chemother (2008) 1.04
Peroxiredoxins in parasites. Antioxid Redox Signal (2012) 1.01
Reactive oxygen species-mediated immunity against Leishmania mexicana and Serratia marcescens in the sand phlebotomine fly Lutzomyia longipalpis. J Biol Chem (2012) 0.94
From genomes to vaccines: Leishmania as a model. Philos Trans R Soc Lond B Biol Sci (2002) 0.92
Oxidant generation by single infected monocytes after short-term fluorescence labeling of a protozoan parasite. Infect Immun (2006) 0.91
Reactive oxygen species scavenging by catalase is important for female Lutzomyia longipalpis fecundity and mortality. PLoS One (2011) 0.91
A comparative study of type I and type II tryparedoxin peroxidases in Leishmania major. FEBS J (2007) 0.91
Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole. Parasitol Res (2008) 0.90
Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c Mice. Infect Immun (2006) 0.88
Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi. Am J Trop Med Hyg (2012) 0.83
Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence. PLoS Negl Trop Dis (2014) 0.81
Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum lines. Parasit Vectors (2014) 0.80
Leishmania subtilisin is a maturase for the trypanothione reductase system and contributes to disease pathology. J Biol Chem (2010) 0.80
Differential Immune Response against Recombinant Leishmania donovani Peroxidoxin 1 and Peroxidoxin 2 Proteins in BALB/c Mice. J Immunol Res (2015) 0.77
Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management. PLoS Negl Trop Dis (2016) 0.75
Biochemical and biophysical characterization of Leishmania donovani gamma-glutamylcysteine synthetase. Biochem Biophys Rep (2016) 0.75
Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med (1985) 3.44
Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science (1985) 2.94
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med (1995) 2.30
Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature (1982) 2.29
Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature (1993) 2.26
Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol Microbiol (2000) 2.19
Lipoprotein lipase suppression in 3T3-L1 cells by a haematoprotozoan-induced mediator from peritoneal exudate cells. Parasite Immunol (1984) 2.03
Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis (2001) 2.02
Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol (1991) 2.00
Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J Biol Chem (1991) 1.99
In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.97
A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology (1984) 1.89
Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect Immun (1991) 1.84
Expression of the natural resistance gene Lsh in resident liver macrophages. Infect Immun (1984) 1.82
Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J Biol Chem (1995) 1.80
Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. J Immunol (1993) 1.78
Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun (2004) 1.65
Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases. Biochemistry (1986) 1.62
Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J (1997) 1.58
Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J Med Chem (1998) 1.55
Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tuber Lung Dis (1997) 1.50
Localisation of Nramp1 in macrophages: modulation with activation and infection. J Cell Sci (1998) 1.50
Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. Eur J Biochem (1995) 1.50
Ovothiol and trypanothione as antioxidants in trypanosomatids. Mol Biochem Parasitol (2001) 1.46
The structure of reduced tryparedoxin peroxidase reveals a decamer and insight into reactivity of 2Cys-peroxiredoxins. J Mol Biol (2000) 1.44
Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet (1999) 1.43
Modern vaccines. Parasitic diseases. Lancet (1990) 1.41
IL-13 is a susceptibility factor for Leishmania major infection. J Immunol (2000) 1.38
NH2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. J Exp Med (1994) 1.37
Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun (2004) 1.36
Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J (2001) 1.36
Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol Med (1995) 1.32
Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun (1999) 1.32
The molecular karyotype of the megabase chromosomes of Trypanosoma brucei and the assignment of chromosome markers. Mol Biochem Parasitol (1998) 1.30
Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. Structure (1999) 1.28
Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy. J Exp Med (1986) 1.28
An improved technique for the cultivation of Plasmodium falciparum in vitro without daily medium change. Ann Trop Med Parasitol (1985) 1.27
Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata. Biochemistry (1987) 1.26
The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol Today (1999) 1.26
Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect Immun (1994) 1.25
Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology (2007) 1.23
A 7.1 kb linear DNA molecule of Theileria parva has scrambled rDNA sequences and open reading frames for mitochondrially encoded proteins. EMBO J (1994) 1.23
Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem (1987) 1.21
Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis (2000) 1.20
Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice. Infect Immun (1984) 1.20
Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase. Eur J Biochem (1995) 1.19
Levels of polyamines, glutathione and glutathione-spermidine conjugates during growth of the insect trypanosomatid Crithidia fasciculata. J Gen Microbiol (1988) 1.19
Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. Infect Immun (1997) 1.18
Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release. Immunology (1994) 1.17
Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: the effects of parasite dose, cyclophosphamide and sublethal irradiation. Parasite Immunol (1983) 1.16
Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus. Mol Microbiol (1998) 1.16
Fetal alcohol exposure and temporal vulnerability: regional differences in cell loss as a function of the timing of binge-like alcohol exposure during brain development. Alcohol Clin Exp Res (1999) 1.14
SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa. Int J Tuberc Lung Dis (2004) 1.14
Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovani. Parasite Immunol (1987) 1.14
Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival. Proc Natl Acad Sci U S A (1998) 1.14
Nramp1 locus encodes a 65 kDa interferon-gamma-inducible protein in murine macrophages. Biochem J (1997) 1.14
Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immun (2007) 1.14
Identification of a novel, thiol-containing co-factor essential for glutathione reductase enzyme activity in trypanosomatids. Mol Biochem Parasitol (1985) 1.13
Trypanothione dependent peroxide metabolism in Crithidia fasciculata and Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.13
Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution. Eur J Biochem (1993) 1.13
Glutathionylspermidine metabolism in Escherichia coli. Biochem J (1995) 1.13
Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. Biochem J (1992) 1.12
Polymorphism in the interferon-gamma receptor-1 gene and susceptibility to pulmonary tuberculosis in The Gambia. Scand J Immunol (2003) 1.12
Ornithine decarboxylase gene deletion mutants of Leishmania donovani. J Biol Chem (1999) 1.10
The high resolution crystal structure of recombinant Crithidia fasciculata tryparedoxin-I. J Biol Chem (1999) 1.10
The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution. Protein Sci (1996) 1.09
"Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. Proc Natl Acad Sci U S A (1988) 1.09
Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice. Immunogenetics (1983) 1.08
Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun (2006) 1.08
Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice. Infect Immun (1989) 1.07
Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun (2003) 1.06
Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. Eur J Immunogenet (1993) 1.06
Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which over-express trypanothione reductase. Sensitivity towards agents that are thought to induce oxidative stress. Eur J Biochem (1993) 1.05
Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP. Genomics (1994) 1.05
Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge. Infect Immun (1998) 1.05
Acquisition of cell-mediated immunity to Leishmania. II. LSH gene regulation of accessory cell function. Immunology (1988) 1.04
Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei. Mol Biochem Parasitol (1987) 1.04
Toxoplasma gondii expressed sequence tags: insight into tachyzoite gene expression. Mol Biochem Parasitol (1996) 1.03
Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun (2010) 1.03
Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages. Immunology (1987) 1.03
Active site of trypanothione reductase. A target for rational drug design. J Mol Biol (1992) 1.02
Surface receptors and transporters of Trypanosoma brucei. Annu Rev Microbiol (1998) 1.02
Genetic analysis of Leishmania mexicana infection in mice: single gene (Scl-2) controlled predisposition to cutaneous lesion development. J Immunogenet (1990) 1.02
Intra and inter-specific microsatellite variation in the Leishmania subgenus Viannia. Mol Biochem Parasitol (1999) 1.02
Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden. Cancer Epidemiol Biomarkers Prev (2000) 1.02
Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol (2001) 1.01
Characterisation of pentamidine-resistant Trypanosoma brucei brucei. Mol Biochem Parasitol (1995) 1.01
Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology (1995) 1.01
Trypanosome glucose transporters. Mol Biochem Parasitol (1998) 1.01
Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum (2000) 1.00
Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations. Infect Immun (1988) 1.00
Purification of glutathionylspermidine and trypanothione synthetases from Crithidia fasciculata. Protein Sci (1992) 1.00
Multiple causes of size variation in the diploid megabase chromosomes of African tyrpanosomes. Chromosome Res (1999) 0.99
Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals. Eur J Biochem (1994) 0.99
Synthesis of N-benzyloxycarbonyl-L-cysteinylglycine 3-dimethylaminopropylamide disulfide: a cheap and convenient new assay for trypanothione reductase. Anal Biochem (1991) 0.99
Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules. Eur J Immunol (1992) 0.99
Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet (1996) 0.99